FDG-PET in cervical cancer: staging, re-staging and follow-up

References

• Lin WC, et al. Usefulness of 18F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol. 2003; 89(1)73–6
   PubMed Web of Science ®Google Scholar
• Yeh LS, et al. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings. Oncol Rep. 2002; 9(6)1289–92
   PubMed Web of Science ®Google Scholar
• Havrilesky LJ, et al. The role of PET scanning in the detection of recurrent cervical cancer. Gynecol Oncol. 2003; 90(1)186–90
   PubMed Web of Science ®Google Scholar
• Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med. 2003; 44(3)347–52
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Siegel BA, Dehdashti F. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol. 2001; 19(17)3745–9
   PubMed Web of Science ®Google Scholar
• Benedet JL, et al. Carcinoma of the cervix uteri. Int J Gynaecol Obstet 2003; 1(83 Suppl)41–78
   Web of Science ®Google Scholar
• Ho CM, et al. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol. 2004; 93(2)458–64
   PubMed Web of Science ®Google Scholar
• Kristensen GB, Abeler VM, Risberg B, Tropé C, Bryne M. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma. Gynecol Oncol. 1999; 74(2)245–51
   PubMed Web of Science ®Google Scholar
• Grisaru D, et al. Does histology influence prognosis in patients with early-stage cervical carcinoma?. Cancer. 2001; 92(12)2999–3004
   PubMed Web of Science ®Google Scholar
• Creasman WT, Kohler MF. Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?. Gynecol Oncol. 2004; 92(2)525–9
   PubMed Web of Science ®Google Scholar
• Bodurka-Bevers D, et al. Posttherapy surveillance of women with cervical cancer: an outcomes analysis. Gynecol Oncol. 2000; 78(2)187–93
   PubMed Web of Science ®Google Scholar
• Grigsby PW, Siegel BA, Dehdashti F, Mutch DG. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys. 2003; 55(4)907–13
   PubMed Web of Science ®Google Scholar
• Chung HH, et al. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis. Gynecol Oncol. 2006; 103(1)165–70
   PubMed Web of Science ®Google Scholar
• Stehman FB, et al. Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer. 1991; 67(11)2776–85
   PubMed Web of Science ®Google Scholar
• Cosin JA, et al. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer. 1998; 82(11)2241–8
   PubMed Web of Science ®Google Scholar
• Morice P, et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol. 1999; 73(1)106–10
   PubMed Web of Science ®Google Scholar
• Havrilesky LJ, Kulasingam SL, Matchar DB, Myers ER. FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol. 2005; 97(1)183–91
   PubMed Web of Science ®Google Scholar
• Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA. 1997; 278(13)1096–101
   PubMed Web of Science ®Google Scholar
• Tsai CS, et al. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Int J Radiat Oncol Biol Phys. 2004; 58(5)1506–12
   PubMed Web of Science ®Google Scholar
• Choi HJ, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer. 2006; 106(4)914–22
   PubMed Web of Science ®Google Scholar
• Singh AK, Grigsby PW, Dehdashti F, Herzog TJ, Siegel BA. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma. Int J Radiat Oncol Biol Phys. 2003; 56(2)489–93
   PubMed Web of Science ®Google Scholar
• Belhocine T, et al. Contribution of whole-body 18F-FDG PET imaging in the management of cervical cancer. Gynecol Oncol. 2002; 87(1)90–7
   PubMed Web of Science ®Google Scholar
• Lai CH, et al. Restaging of recurrent cervical carcinoma with dual-phase (18F)fluoro-2-deoxy-d-glucose positron emission tomography. Cancer. 2004; 100(3)544–52
   PubMed Web of Science ®Google Scholar